NYSE:A - Agilent Technologies Stock Price, News, & Analysis

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Agilent Technologies declared a quarterly dividend on Wednesday, November 14th. Stockholders of record on Monday, December 31st will be given a dividend of $0.164 per share on Wednesday, January 23rd. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date is Friday, December 28th. This is a boost from Agilent Technologies's previous quarterly dividend of $0.15. View Agilent Technologies' Dividend History.

Agilent Technologies announced that its Board of Directors has initiated a share buyback plan on Monday, November 19th 2018, which permits the company to repurchase $1,750,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to reacquire up to 8.8% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's leadership believes its shares are undervalued.

Agilent Technologies Inc (NYSE:A) posted its quarterly earnings results on Monday, November, 19th. The medical research company reported $0.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.74 by $0.07. The medical research company had revenue of $1.29 billion for the quarter, compared to analyst estimates of $1.26 billion. Agilent Technologies had a return on equity of 19.84% and a net margin of 6.43%. The business's quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the company earned $0.67 earnings per share. View Agilent Technologies' Earnings History.

Agilent Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, February 13th 2019. View Earnings Estimates for Agilent Technologies.

Agilent Technologies updated its FY19 earnings guidance on Monday, November, 19th. The company provided earnings per share (EPS) guidance of $3.00-3.05 for the period, compared to the Thomson Reuters consensus estimate of $2.97. The company issued revenue guidance of $5.13-5.17 billion, compared to the consensus revenue estimate of $5.19 billion.Agilent Technologies also updated its FY 2019 guidance to $3.00-3.05 EPS.

9 analysts have issued 12-month price targets for Agilent Technologies' shares. Their forecasts range from $70.00 to $89.00. On average, they expect Agilent Technologies' stock price to reach $78.25 in the next twelve months. This suggests a possible upside of 16.2% from the stock's current price. View Analyst Price Targets for Agilent Technologies.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 1 hold rating and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Agilent Technologies.

Media stories about A stock have trended positive this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Agilent Technologies earned a media sentiment score of 2.1 on InfoTrie's scale. They also assigned media stories about the medical research company a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an effect on the stock's share price in the near future.

Agilent Technologies saw a increase in short interest during the month of October. As of October 15th, there was short interest totalling 5,266,314 shares, an increase of 48.8% from the September 28th total of 3,538,270 shares. Based on an average trading volume of 2,755,274 shares, the days-to-cover ratio is presently 1.9 days. Approximately 1.7% of the company's stock are short sold. View Agilent Technologies' Current Options Chain.

Some companies that are related to Agilent Technologies include Illumina (ILMN), Waters (WAT), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories, Inc. Class B (BIO.B), Bio-Rad Laboratories (BIO), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Pacific Biosciences of California (PACB), Accelerate Diagnostics (AXDX), Quanterix (QTRX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT) and Harvard Bioscience (HBIO).

Agilent Technologies' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.15%), OppenheimerFunds Inc. (2.69%), FMR LLC (2.13%), American Century Companies Inc. (1.68%), Primecap Management Co. CA (1.45%) and Cantillon Capital Management LLC (1.11%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, James Cullen, Mark Doak, Michael R Mcmullen, Patrick G Hagan, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.

A stock was sold by a variety of institutional investors in the last quarter, including MERIAN GLOBAL INVESTORS UK Ltd, FMR LLC, Renaissance Technologies LLC, Victory Capital Management Inc., BlackRock Inc., Putnam Investments LLC, Deutsche Bank AG and Capital Fund Management S.A.. Company insiders that have sold Agilent Technologies company stock in the last year include Boon Hwee Koh, Didier Hirsch, Heidi Fields, Jacob Thaysen, Mark Doak, Michael R Mcmullen, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies.

A stock was purchased by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., OppenheimerFunds Inc., American Century Companies Inc., Pictet Asset Management Ltd., Man Group plc, Redmile Group LLC, WINTON GROUP Ltd and Neuberger Berman Group LLC. View Insider Buying and Selling for Agilent Technologies.

Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of A stock can currently be purchased for approximately $67.33.

Agilent Technologies has a market capitalization of $19.96 billion and generates $4.91 billion in revenue each year. The medical research company earns $684 million in net income (profit) each year or $2.79 on an earnings per share basis. Agilent Technologies employs 13,500 workers across the globe.

The official website for Agilent Technologies is http://www.agilent.com.

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 408-345-8886 or via email at [email protected]